Basiliximab injection
Basiliximab injection
What is this medicine?
BASILIXIMAB (ba sil IK si mab) suppresses the immune system. It is used to prevent organ rejection after a transplant.
How should I use this medicine?
This medicine is for injection or infusion into a vein. It is given by a health care professional in a hospital or clinic setting.
Talk to your pediatrician regarding the use of this medicine in children. Special care may be needed.
What side effects may I notice from receiving this medicine?
Side effects that you should report to your doctor or health care professional as soon as possible:
allergic reactions like skin rash, itching or hives, swelling of the face, lips, or tongue
breathing problems
fever, chills, or other signs of infection
Side effects that usually do not require medical attention (report to your doctor or health care professional if they continue or are bothersome):
constipation
difficulty sleeping
headache
nausea, vomiting
pain at site where injected
stomach upset
tremors
What may interact with this medicine?
vaccines
What if I miss a dose?
This does not apply.
Where should I keep my medicine?
This drug is given in a hospital or clinic and will not be stored at home.
What should I tell my health care provider before I take this medicine?
They need to know if you have any of these conditions:
infection
an unusual or allergic reaction to basiliximab, mouse proteins, mannitol, other medicines, foods, dyes, or preservatives
pregnant or trying to get pregnant
breast-feeding
What should I watch for while using this medicine?
Your condition will be monitored carefully while you are receiving this medicine.
This medicine may increase your risk of getting an infection. Stay away from people who are sick. See your doctor if you get an infection.
Talk to your doctor if you have surgery within the 12 months of taking this medicine.
This medicine may increase your risk of getting certain kinds of cancer. Talk to your doctor about healthy lifestyle choices, important screenings, and your risk.
Updated:  
September 30, 2017